Chelsea Wilson
Medical · Indianapolis, INNPI 1447694658
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,423 of the $5,158 with a category attached, or 85.8%. Inari Medical, Inc. accounts for 61.9% of it on its own, with 10 other manufacturers making up the rest.
Across 169 payments — averaging $30.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$3K
- Stryker$688
- Trisalus Life Sciences, Inc.$462
- Boston Scientific$261
- Imperative Care, Inc$203
- Sirtex Medical Inc$178
- plus $175 from 5 others
What the payments were for
- Travel & lodging$73514%
- Food & beverage$4,42386%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 96 | $3,190 |
| Stryker | 30 | $688 |
| Trisalus Life Sciences, Inc. | 24 | $462 |
| Boston Scientific | 7 | $261 |
| Imperative Care, Inc | 4 | $203 |
| Sirtex Medical Inc | 2 | $178 |
| Philips North America LLC | 1 | $74 |
| Bard Peripheral Vascular, Inc. | 2 | $39 |
| Terumo Medical Corporation | 1 | $25 |
| Teleflex LLC | 1 | $19 |
| Avanos Medical | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,158 in reported general payments places this provider in the 85th percentile of 273 medical providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 36 | $264 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $195 |
| Ondansetron Hcl | 25 | $131 |
| Clindamycin Hcl | 18 | $109 |
| Pantoprazole Sodium | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Other medical in Indianapolis
- Meggie BeckleyIndianapolis$125K
- Jennifer ConnerIndianapolis$98K
- Jennifer IrwinIndianapolis$34K
- Andrew BurnsIndianapolis$13K
- Bridget WilliamsonIndianapolis$11K
- Lindsay MuellerIndianapolis$9K
- Meredith SlayterIndianapolis$8K
- Rachel SandersonIndianapolis$4K
- Ryan StromIndianapolis$4K
- Amanda EckhardtIndianapolis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.